Aardvark Therapeutics, Inc. Common Stock

AARDNASDAQ • USD
1.47 USD
↗ 0.14 (10.60%)🟢PRE MARKET (AS OF 05:14 AM EST)
🟢Market: OPEN

Aardvark Therapeutics, Inc. Common Stock (AARD) trades at $1.47 per share. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 13, 2026.

Open?$1.34
High?$1.59
Low?$1.34
Prev. Close?$1.33
Volume?689
Avg. Volume?1.2M
VWAP?$1.45
Rel. Volume?0.00x
Bid / Ask
Bid?$1.13 × 100
Ask?$1.94 × 100
Spread?$0.81
Midpoint?$1.54
Valuation & Ratios
Market Cap?29.1M
Shares Out?N/A
Float?12.1M
Float %?55.5%
P/E Ratio?N/A
P/B Ratio?0.51
EPS?-$3.32
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
Employees
28
Market Cap
29.1M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2025-02-13
Address
4370 LA JOLLA VILLAGE DRIVE
SAN DIEGO, CA 92122
Phone: (858) 225-7696
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
23
Short Sent.?
43
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.08Distress
Confidence?50%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?8.55%Elevated
Short Interest?1.0M
Days to Cover?1.0
Free Float12.1M
Avg Daily Volume2.8M
Settlement Date2026-10-30
Financial Health
Current Ratio?9.11Strong
Quick Ratio?9.11Strong
Cash Ratio?8.58Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.51CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.4CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-126.3%WEAK▾
ROA?
S&P
3
-112.3%WEAK▾
Cash Flow & Enterprise
FCF?$-66814000
Enterprise Value?$-31219610
Fundamentals ratios updated end of day